Search

Watch our scientists discuss how the Geoffrey Beene Center helped Memorial Sloan Kettering establish a progressive approach to modern cancer research.

… Friday, July 19, 2013 Summary Watch our scientists discuss how the Geoffrey Beene Center helped Memorial Sloan Kettering establish a progressive approach to modern cancer research. VIDEO | 04:29 A Look Inside the Geoffrey Beene Cancer Research Center Video Details For the past seven years, the Geoffrey

Johanna Joyce, of the Sloan Kettering Institute's Cancer Biology and Genetics Program, has been named the first incumbent of a Geoffrey Beene Junior Faculty Chair.

… Sunday, April 1, 2007 Summary Johanna Joyce, of the Sloan Kettering Institute’s Cancer Biology and Genetics Program, has been named the first incumbent of a Geoffrey Beene Junior Faculty Chair. Johanna Joyce, of the Sloan Kettering Institute’s Cancer Biology and Genetics Program , has been named the

Meet Ben Hegel, a senior program coordinator in the Sloan Kettering Institute. “My introduction to Pride in college was through a celebratory lens,” says Ben. “But my relationship to Pride has changed.” He still celebrates, but he points out that the Pride March is just that — a march, not a parade. “It was started by marginalized people who were marching for their rights.”

… Wednesday, June 23, 2021 Ben Hegel is a swimmer. He has loved the water since his boyhood in New Hampshire, where he spent summers jumping off a covered bridge into the local brook with friends — the kind of childhood activity that made his future husband ask him if he grew up in Mayberry, the iconic

Memorial Sloan Kettering Cancer Center (MSK) is accepting applications for the 2025 Cohort of the MSK Innovation Hub (iHub) Challenge program. Digital health companies with innovations leveraging AI to address critical issues in the drug discovery process are encouraged to apply.

… Wednesday, June 4, 2025 Memorial Sloan Kettering Cancer Center (MSK) is accepting applications for the 2025 Cohort of the MSK Innovation Hub (iHub) Challenge program. Digital health companies with innovations leveraging AI to address critical issues in the drug discovery process are encouraged to apply

A new treatment that selectively seeks out prostate cancer cells shows great promise for treating advanced forms of the disease.

… Thursday, June 3, 2021 Update: On March 23, 2022, the US Food and Drug Administration approved 177 Lu-PSMA-617 for prostate cancer that has spread and grown resistant to other drugs. “FDA approval of this therapy will enable even more people who had essentially been given death sentences to survive and

Meet Cesar Figueroa Ortiz, who says, “The mission of MSK really resonated with me, all the employees seemed very happy, and the patients said great things about their care.”

… Wednesday, October 13, 2021 For  Cesar Figueroa Ortiz , New York City is his long-awaited home. As a native of Bogotá, Colombia, he remembers stepping out of a subway station into Times Square several years ago and finding himself surrounded by throngs of people speaking multiple languages. “I had never

Memorial Sloan Kettering Cancer Center (MSK) is partnering with DigitasLBi and Phase2 to help expand MSK's digital reach.

… Thursday, June 19, 2014 Memorial Sloan Kettering Cancer Center (MSK) today announced the appointment of DigitasLBi as its digital agency of record and Phase2 as its Drupal technology partner. Memorial Sloan Kettering’s digital reach is significant, and the institution is viewed as one of the country’

Memorial Sloan Kettering and Quest Diagnostics announced a joint collaboration that will utilize MSK’s clinical and research insights into gene mutations associated with solid tumors.

… Sunday, June 1, 2014 Diagnostic insights into gene mutations in solid tumor cancers will aid therapy selection and prognosis for patients and advance research Memorial Sloan Kettering Cancer Center, the world’s oldest and largest private cancer center, and Quest Diagnostics (NYSE: DGX), the world’s leading

Learn about some of the most important clinical advances made at MSK in 2021.

… Wednesday, December 22, 2021 In 2021, Memorial Sloan Kettering Cancer Center doctors and scientists continued to make major discoveries that will improve the treatment of cancer. Philanthropic donations provided critical support for much of this research, allowing clinical researchers to pursue innovative

Long-awaited results of clinical trials testing targeted drugs and immunotherapy combinations were on offer at the annual American Association for Cancer Research (AACR) conference.

… Monday, April 18, 2016 Summary MSK scientists featured prominently in the opening days of the annual AACR conference, held this year in New Orleans. They presented new data from clinical trials of both targeted drugs and immunotherapies, and were recognized for their scientific accomplishments. Highlights